The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation
The FASEB Journal · 31.01.2024 · 38 (2)
DOI: 10.1096/fj.202301557rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.01.2024. Verfasst von Emily Willems und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium. Hauptthemen laut MEDLINE: Cuprizone, Demyelinating Diseases, Thiazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Research and Development (JRD).
Abstract (Originalsprache)
Sphingosine‐1‐phosphate receptor (S1PR) modulators are clinically used to treat relapse‐remitting multiple sclerosis (MS) and the early phase of progressive MS when inflammation still prevails. In the periphery, S1PR modulators prevent lymphocyte egress from lymph nodes, hence hampering neuroinflammation. Recent findings suggest a role for S1PR modulation in remyelination. As the Giα‐coupled S1P1 subtype is the most prominently expressed S1PR in oligodendrocyte precursor cells (OPCs), selective modulation (functional antagonism) of S1P1 may have direct effects on OPC functionality. We hypothesized that functional antagonism of S1P1 by ponesimod induces remyelination by boosting OPC differentiation. In the cuprizone mouse model of demyelination, we found ponesimod to decrease the latency time of visual evoked potentials compared to vehicle conditions, which is indicative of functional remyelination. In addition, the Y maze spontaneous alternations test revealed that ponesimod reversed cuprizone‐induced working memory deficits. Myelin basic protein (MBP) immunohistochemistry and transmission electron microscopy of the corpus callosum revealed an increase in myelination upon ponesimod treatment. Moreover, treatment with ponesimod alone or in combination with A971432, an S1P5 monoselective modulator, significantly increased primary mouse OPC differentiation based on O4 immunocytochemistry. In conclusion, S1P1 functional antagonism by ponesimod increases remyelination in the cuprizone model of demyelination and significantly increases OPC differentiation in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
- Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
- University MS Center (UMSC) Hasselt-Pelt, Hasselt, Belgium.
- Department of Cardio and Organ Systems, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
- Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
- Janssen Research & Development, LLC, Titusville, New Jersey, USA.
ORCID-Profile: Emily Willems, Melissa Schepers, Esther Wolfs, Niels Hellings, Tim Vanmierlo
Förderung
- Janssen Research and Development (JRD)
Zitieren
APA
Willems, E., Schepers, M., Piccart, E., Wolfs, E., Hellings, N., Ait-Tihyaty, M., & Vanmierlo, T. (2024). The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation. The FASEB Journal, 38(2). https://doi.org/10.1096/fj.202301557rr
Vancouver
Willems E, Schepers M, Piccart E, Wolfs E, Hellings N, Ait-Tihyaty M, et al. The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation. The FASEB Journal. 2024;38(2). doi:10.1096/fj.202301557rr
BibTeX
@article{Willems2024,
author = {Willems, Emily and Schepers, Melissa and Piccart, Elisabeth and Wolfs, Esther and Hellings, Niels and Ait-Tihyaty, Maria and Vanmierlo, Tim},
title = {The sphingosine‐1‐phosphate receptor 1 modulator ponesimod repairs cuprizone‐induced demyelination and induces oligodendrocyte differentiation},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {2},
doi = {10.1096/fj.202301557rr}
}
EUVIMED